ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » District of Columbia » Cardiovascular Disease

Top Cardiovascular Disease Prescribers in District of Columbia

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MARCO CAVAGNA M.D.

Cardiovascular Disease

1,040

$47.2K

166
134 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 32%

$45
Average prescription price

Avg: $73

HENRY MARSH M.D.

Cardiovascular Disease

1,035

$90.3K

85
74 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 32%

$87
Average prescription price

Avg: $73

CHARLES RACKLEY MD

Cardiovascular Disease

1,024

$124K

118
100 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

40%
prescriptions for brand name drugs

Avg: 32%

$121
Average prescription price

Avg: $73

OTELIA RANDALL MD

Cardiovascular Disease

1,002

$57.3K

55
37 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 32%

$57
Average prescription price

Avg: $73

MITCHELL DUNN MD

Cardiovascular Disease

981

$111K

84
80 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 32%

$113
Average prescription price

Avg: $73

REGINALD ROBINSON MD

Cardiovascular Disease

978

$77.8K

126
94 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 32%

$80
Average prescription price

Avg: $73

EDWARD BELTON MD

Cardiovascular Disease

968

$55.4K

26
26 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 32%

$57
Average prescription price

Avg: $73

ANTHONY WATKINS MD

Cardiovascular Disease

955

$77.7K

119
110 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 32%

$81
Average prescription price

Avg: $73

CYNTHIA TRACY M.D.

Cardiovascular Disease

900

$76.4K

92
73 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 32%

$85
Average prescription price

Avg: $73

LOWELL WEISS MD

Cardiovascular Disease

874

$66.6K

69
64 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 32%

$76
Average prescription price

Avg: $73

JOSEPH LODATO M.D.

Cardiovascular Disease

860

$47.5K

228
206 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 32%

$55
Average prescription price

Avg: $73

ALLEN SOLOMON M.D.

Cardiovascular Disease

828

$65.6K

95
84 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 32%

$79
Average prescription price

Avg: $73

BRIAN CHOI M.D.

Cardiovascular Disease

775

$58.6K

71
48 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

39%
prescriptions for brand name drugs

Avg: 32%

$76
Average prescription price

Avg: $73

SUSAN BENNETT M.D.

Cardiovascular Disease

761

$85.3K

102
94 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

42%
prescriptions for brand name drugs

Avg: 32%

$112
Average prescription price

Avg: $73

RICHARD KATZ M.D.

Cardiovascular Disease

753

$41K

92
73 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 32%

$54
Average prescription price

Avg: $73

NICHOLAS GWOZDZ M.D.

Cardiovascular Disease

753

$82.9K

76
73 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

39%
prescriptions for brand name drugs

Avg: 32%

$110
Average prescription price

Avg: $73

BERNARD WAGMAN MD

Cardiovascular Disease

721

$83.1K

118
92 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

37%
prescriptions for brand name drugs

Avg: 32%

$115
Average prescription price

Avg: $73

BENJAMIN LEE M.D.

Cardiovascular Disease

714

$54.7K

91
83 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

37%
prescriptions for brand name drugs

Avg: 32%

$77
Average prescription price

Avg: $73

ROBERT LAGER MD

Cardiovascular Disease

684

$69.9K

85
77 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

43%
prescriptions for brand name drugs

Avg: 32%

$102
Average prescription price

Avg: $73

DAVID PEARLE

Cardiovascular Disease

607

$60.3K

74
64 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

37%
prescriptions for brand name drugs

Avg: 32%

$99
Average prescription price

Avg: $73

JOSEPH JOSON M.D.

Cardiovascular Disease

601

$39.2K

176
165 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 32%

$65
Average prescription price

Avg: $73

KHANH DECAREAU MD

Cardiovascular Disease

541

$39.3K

94
68 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

41%
prescriptions for brand name drugs

Avg: 32%

$73
Average prescription price

Avg: $73

JOHN FRANCIS MD

Cardiovascular Disease

480

$20K

53
40 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 32%

$42
Average prescription price

Avg: $73

DAISY LAZAROUS MD

Cardiovascular Disease

408

$39K

66
58 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 32%

$96
Average prescription price

Avg: $73

MARK HOFMEYER M.D.

Cardiovascular Disease

383

$22.4K

50
14 are 65+

22%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 32%

$58
Average prescription price

Avg: $73

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank